Published Date: 09 Dec 2024
News, features, and commentary about cancer-related issues
Read Full NewsOcular motor cranial neuropathy is associated with an increased risk for Parkinson’s disease, a new study shows.
Traumatic brain injury is bidirectionally associated with the incidence of stroke, dementia, epilepsy, and Parkinson’s disease, a retrospective study shows.
A large database study found overall 5- and 10-year improvement in pediatric cancer survival, but some cancers lag others, and demographic factors seem to influence trends.
Workforce projections show an uneven distribution of rheumatologists in the US, with notable shortages in nonmetropolitan areas and certain states and districts.
A phase 2 trial assesses fixed-duration epcoritamab monotherapy as first-line therapy for frail older adults with newly diagnosed anthracycline-ineligible large B-cell lymphoma.
All adults aged 65-74 with a chronic respiratory condition or a weakened immune system will be offered the RSV vaccine from September, NHS England has confirmed.
Emerging evidence suggests coffee influences gut microbiota through bioactive compounds beyond caffeine, with potential effects on digestive and metabolic health.
1.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
2.
In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.
3.
PSA Screening May Modestly Curb Prostate Cancer Deaths
4.
Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.
5.
An ancient signaling pathway and 20 years of research offer hope for rare cancer
1.
Immune Regulation of Blood Cell Development
2.
Tumor Microenvironment Mapping in Cancer Care
3.
Emerging Insights in Hematology for Better Care
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Unlocking Immunity: TILs, Immunotherapy Biomarkers, and Toxicity Management in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation